Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Lenz Therapeutics, Inc.(LENZ) | 0 | 2,656,888 | +2,656,888 | 0 | 123,758 | 58.25% | +123,758 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,652,922 | 5,652,922 | 0 | 25,495 | 41,888 | 19.72% | +16,393 |
| Contineum Therapeutics, Inc.(CTNM) | 542,628 | 542,628 | 0 | 2,154 | 6,376 | 3.00% | +4,222 |
| Adverum Biotechnologies, Inc. | 506,821 | 506,821 | 0 | 1,090 | 2,296 | 1.08% | +1,206 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 3,679 | 4,658 | 2.19% | +979 |
| Tempest Therapeutics, Inc.(TPST) | 269,772 | 269,772 | 0 | 1,834 | 2,773 | 1.31% | +939 |
| Skye Bioscience, Inc.(SKYE) | 2,007,704 | 2,007,704 | 0 | 8,392 | 7,890 | 3.71% | -502 |
| Jade Biosciences, Inc. | 1,525,820 | 1,525,820 | 0 | 15,243 | 13,168 | 6.20% | -2,075 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 148,831 | -349,727 | 24,250 | 9,646 | 4.54% | -14,604 |